Home › Thyroid Nodule › NCT07226804
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Eligibility Criteria * Scheduled to undergo ultrasound guided nsPFA as standard of care * Age 18 to 80 years. * Capable of providing independent consent. * Presence of biopsy-confirmed benign thyroid nodule , defined as one of the following: * Benign FNA X 2 or * Benign US guided FNA X 1 + benign thyroid nodule ultrasound appearance (TI-RADS 2) or * Benign FNA X 1 and radiographic/laboratory evidence of functional nature * Nodule measuring \>2cm in greatest dimension * Presence of compressive symptoms reasonably attributable to thyroid nodule (i.e. pressure sensation, dysphagia, dysphonia, respiratory distress) * No abnormal cervical lymph nodes during screening visit . Exclusion Criteria * Age \<18 * Patients considered unsuitable for nsPFA by the treating physician
About the study
To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.
What is being tested
- Questionnaire (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 30 · Started: Nov 14, 2025
Contact the study team
- Victoria E Banuchi, MD · Phone: 346-217-8668
Official record on ClinicalTrials.gov — NCT07226804
Locations in the U.S.
| Texas | MD Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.